Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Palese

Showing results (261-270 of 291) with videos related to

Pageof 30
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 27, 2014
Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humansAli H Ellebedy, Florian Krammer, Gui-Mei Li, et al.
Frontiers in Immunology|April 1, 2025
Mucosal multivalent NDV-based vaccine provides cross-reactive immune responses against SARS-CoV-2 variants in animal modelsIrene González-Domínguez, Adam Abdeljawad, Tsoi Ying Lai, et al.
Plos One|May 8, 2015
High Affinity Antibodies against Influenza Characterize the Plasmablast Response in SLE Patients After VaccinationKaval Kaur, Nai-Ying Zheng, Kenneth Smith, et al.
Science Translational Medicine|June 3, 2021
First exposure to the pandemic H1N1 virus induced broadly neutralizing antibodies targeting hemagglutinin head epitopesJenna J Guthmiller, Julianna Han, Lei Li, et al.
Nature Immunology|October 15, 2025
Influenza vaccine based on AS03-adjuvanted chimeric HA induces long-lived stalk-specific plasma cells in bone marrow and lymph nodes of nonhuman primatesAkil Akhtar, Tiffany M Styles, Chunyang Gu, et al.
Mbio|September 21, 2021
Safety and Immunogenicity of a Newcastle Disease Virus Vector-Based SARS-CoV-2 Vaccine Candidate, AVX/COVID-12-HEXAPRO (Patria), in PigsJesús Horacio Lara-Puente, Juan Manuel Carreño, Weina Sun, et al.
Science Translational Medicine|February 15, 2023
An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccinationJuan Manuel Carreño, Ariel Raskin, Gagandeep Singh, et al.
Nature Communications|October 28, 2021
A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responsesWeina Sun, Yonghong Liu, Fatima Amanat, et al.
Lancet (London, England)|February 23, 2020
Statement in support of the scientists, public health professionals, and medical professionals of China combatting COVID-19Charles Calisher, Dennis Carroll, Rita Colwell, et al.
Nature|December 23, 2009
Human host factors required for influenza virus replicationRenate König, Silke Stertz, Yingyao Zhou, et al.
Pageof 30

Showing results (261-270 of 291) with videos related to

Sort By:
Pageof 30
Proceedings of the National Academy of Sciences of the United States of America|August 27, 2014
Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humansAli H Ellebedy, Florian Krammer, Gui-Mei Li, et al.
Frontiers in Immunology|April 1, 2025
Mucosal multivalent NDV-based vaccine provides cross-reactive immune responses against SARS-CoV-2 variants in animal modelsIrene González-Domínguez, Adam Abdeljawad, Tsoi Ying Lai, et al.
Plos One|May 8, 2015
High Affinity Antibodies against Influenza Characterize the Plasmablast Response in SLE Patients After VaccinationKaval Kaur, Nai-Ying Zheng, Kenneth Smith, et al.
Science Translational Medicine|June 3, 2021
First exposure to the pandemic H1N1 virus induced broadly neutralizing antibodies targeting hemagglutinin head epitopesJenna J Guthmiller, Julianna Han, Lei Li, et al.
Nature Immunology|October 15, 2025
Influenza vaccine based on AS03-adjuvanted chimeric HA induces long-lived stalk-specific plasma cells in bone marrow and lymph nodes of nonhuman primatesAkil Akhtar, Tiffany M Styles, Chunyang Gu, et al.
Mbio|September 21, 2021
Safety and Immunogenicity of a Newcastle Disease Virus Vector-Based SARS-CoV-2 Vaccine Candidate, AVX/COVID-12-HEXAPRO (Patria), in PigsJesús Horacio Lara-Puente, Juan Manuel Carreño, Weina Sun, et al.
Science Translational Medicine|February 15, 2023
An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccinationJuan Manuel Carreño, Ariel Raskin, Gagandeep Singh, et al.
Nature Communications|October 28, 2021
A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responsesWeina Sun, Yonghong Liu, Fatima Amanat, et al.
Lancet (London, England)|February 23, 2020
Statement in support of the scientists, public health professionals, and medical professionals of China combatting COVID-19Charles Calisher, Dennis Carroll, Rita Colwell, et al.
Nature|December 23, 2009
Human host factors required for influenza virus replicationRenate König, Silke Stertz, Yingyao Zhou, et al.
Pageof 30